전남대학교 중앙도서관

  • 중앙도서관
  • 여수캠퍼스도서관
  • 법학도서관
  • 치의학도서관
  • 의학도서관

링크메뉴

  • 화면키우기 화면줄이기 화면크기 원래대로
  • S
  • HOME
  • 로그인
  • 전남대
  • ENG
  • CHN

주메뉴

전체메뉴

전자자료 상세검색

전자자료 상세검색

통합검색
상세검색
검색어 [키워드: "Koychev, I."]
총 131건 
※ 페이지 이동 시, 중복 레코드가 제거되므로 초기 검색결과 수와 차이가 있을 수 있습니다.
6/14 페이지 RSS 엑셀파일 출력
검색결과수정
  • 검색범위확장
    • Full Text내 키워드 확장
    • 관련 주제어 확장

    재검색

  • 검색결과제한
    • 원문(Full Text)
    • Peer-Reviewed 학술지
    • 발행년 -

    재검색

  • 자료유형
    • Academic Journals (124)
    • Magazines (5)
    • Conference Materials (2)

    재검색

  • 주제
    • schizophrenia (18)
    • alzheimer disease (17)
    • dementia (10)

    더보기

    재검색

  • 간행물
    • european neuropsychopharmacology (17)
    • psychological medicine (12)
    • the lancet respiratory medicine (8)

    더보기

    재검색

  • 출판사
    • elsevier b.v. (15)
    • cambridge university press (12)
    • elsevier ltd (6)

    더보기

    재검색

  • 언어
    • english (126)

    재검색

  • Publication Year
    • 2011 (3)
    • 2010 (2)
    • 2009 (1)

    더보기

    재검색

  • 수록데이터베이스
    • MEDLINE (66)
    • Science Citation Index Expanded (18)
    • ScienceDirect (15)

    더보기

    재검색

  • PQDTSearch
  • CAJSearch
  • RISSSearch
  • PsycINFOSearch

 

51
Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study. 미리보기

학술저널

issue
PloS one [PLoS One] 2023 Jul 07; Vol. 18 (7), pp. e0285807. Date of Electronic Publication: 2023 Jul 07 (Print Publication: 2023).
Author
Muurling M; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
Pasmooij AMG; Dutch Medicines Evaluation Board, Utrecht, Netherlands.
Koychev I; Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
Roik D; Department of Geriatric Psychiatry, Central Institute for Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
Froelich L; Department of Geriatric Psychiatry, Central Institute for Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
Schwertner E; Division of Clinical Geriatrics, Department of Neurobiology, Department of Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.; Faculty of Psychology, SWPS University of Social Sciences and Humanities, Krakow, Poland.
Religa D; Division of Clinical Geriatrics, Department of Neurobiology, Department of Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.; Theme Inflammation and Aging, Karolinska University Hospital, Huddinge, Sweden.
Abdelnour C; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States of America.
Boada M; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Almici M; Laboratory Alzheimer's Neuroimaging & Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Galluzzi S; Laboratory Alzheimer's Neuroimaging & Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Cardoso S; Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
de Mendonça A; Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
Owens AP; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Kuruppu S; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Gjestsen MT; Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.
Lazarou I; Information Technologies Institute, Center for Research and Technology Hellas (CERTH-ITI), Thessaloniki, Greece.
Gkioka M; Laboratory of Neurodegenerative Diseases, Center for Interdisciplinary Research and Innovation (CIRI-AUTh), Balkan Center, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Tsolaki M; Laboratory of Neurodegenerative Diseases, Center for Interdisciplinary Research and Innovation (CIRI-AUTh), Balkan Center, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Diaz A; Alzheimer Europe, Luxembourg, Luxembourg.
Gove D; Alzheimer Europe, Luxembourg, Luxembourg.
Visser PJ; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.; Division of Clinical Geriatrics, Department of Neurobiology, Department of Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Aarsland D; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.; Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.
Lucivero F; Ethox and Welcome Centre for Ethics and Humanities, University of Oxford, Oxford, United Kingdom.
de Boer C; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
DB Label
Database : MEDLINE
원문보기
Full Text Full Text (원문보기) PLinkFull Text (원문보기) Open Access (PubMed Central)  등재 - SCOPUS  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
53
Path integration selectively predicts midlife risk of Alzheimer's disease. 미리보기

issue
BioRxiv : the preprint server for biology [bioRxiv] 2023 Feb 03. Date of Electronic Publication: 2023 Feb 03.
Author
Newton C; Department of Psychiatry, University of Cambridge; Cambridge, UK.
Pope M; Department of Psychiatry, University of Cambridge; Cambridge, UK.; Cambridgeshire and Peterborough NHS Foundation Trust; Cambridge, UK.
Rua C; Wolfson Brain Imaging Centre, University of Cambridge; Cambridge, UK.
Henson R; Department of Psychiatry, University of Cambridge; Cambridge, UK.
Ji Z; Institute of Cognitive Neuroscience, UCL; London, UK.
Burgess N; Institute of Cognitive Neuroscience, UCL; London, UK.
Rodgers CT; Wolfson Brain Imaging Centre, University of Cambridge; Cambridge, UK.
Stangl M; Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California; Los Angeles, USA.
Dounavi ME; Department of Psychiatry, University of Cambridge; Cambridge, UK.
Castegnaro A; Institute of Cognitive Neuroscience, UCL; London, UK.
Koychev I; Department of Psychiatry, Oxford University; Oxford, UK.
Malhotra P; Department of Brain Sciences, Imperial College London; London, UK.
Wolbers T; German Centre for Neurodegenerative Diseases (DZNE); Magdeburg, Germany.
Ritchie K; Inserm, Institut de Neurosciences; Montpellier, France.
Ritchie CW; Centre for Dementia Prevention, University of Edinburgh; Edinburgh, UK.
O'Brien J; Department of Psychiatry, University of Cambridge; Cambridge, UK.; Cambridgeshire and Peterborough NHS Foundation Trust; Cambridge, UK.
Su L; Department of Psychiatry, University of Cambridge; Cambridge, UK.
Chan D; Institute of Cognitive Neuroscience, UCL; London, UK.
DB Label
Database : MEDLINE
55
Neurodegenerative disease of the brain: a survey of interdisciplinary approaches. 미리보기

학술저널

issue
Journal of the Royal Society, Interface [J R Soc Interface] 2023 Jan; Vol. 20 (198), pp. 20220406. Date of Electronic Publication: 2023 Jan 18.
Author
Davenport F; Freelance writer and King's College London, London, UK.
Gallacher J; Director of Dementias Platform, Department of Psychiatry, University of Oxford, Oxford, UK.
Kourtzi Z; Professor of Cognitive Computational Neuroscience, Department of Psychology, University of Cambridge, UK.
Koychev I; Senior Clinical Researcher, Department of Psychiatry, University of Oxford, Oxford, UK.; Consultant Neuropsychiatrist, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Matthews PM; Department of Brain Sciences and UK Dementia Research Institute Centre, Imperial College London, Oxford, UK.
Oxtoby NP; UCL Centre for Medical Image Computing and Department of Computer Science, University College London, Gower Street, London, UK.
Parkes LM; School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.; Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Manchester, UK.
Priesemann V; Max Planck Group Leader and Fellow of the Schiemann Kolleg, Max Planck Institute for Dynamics and Self-Organization and Bernstein Center for Computational Neuroscience, Göttingen, Germany.
Rowe JB; Department of Clinical Neurosciences, MRC Cognition and Brain Sciences Unit and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, UK.
Smye SW; School of Medicine, University of Leeds, Leeds, UK.
Zetterberg H; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, People's Republic of China.
DB Label
Database : MEDLINE
원문보기
Open Access (PubMed Central)  등재 - SCOPUS  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
56
Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerability. 미리보기

학술저널

issue
Brain communications [Brain Commun] 2022 Oct 21; Vol. 4 (6), pp. fcac267. Date of Electronic Publication: 2022 Oct 21 (Print Publication: 2022).
Author
Ng B; Department of Physiology Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford OX1 3QU, UK.
Rowland HA; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford OX1 3QU, UK.; Department of Psychiatry, University of Oxford, Headington, Oxford OX3 7JX, UK.
Wei T; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford OX1 3QU, UK.; Nuffield Department of Clinical Neurosciences, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford OX1 3QU, UK.
Arunasalam K; Nuffield Department of Clinical Neurosciences, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford OX1 3QU, UK.
Hayes EM; Nuffield Department of Clinical Neurosciences, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford OX1 3QU, UK.
Koychev I; Department of Psychiatry, University of Oxford, Headington, Oxford OX3 7JX, UK.
Hedegaard A; Department of Psychiatry, University of Oxford, Headington, Oxford OX3 7JX, UK.
Ribe EM; Department of Psychiatry, University of Oxford, Headington, Oxford OX3 7JX, UK.
Chan D; Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.
Chessell T; Neuroscience, Innovative Medicines and Early Development, AstraZeneca AKB, Granta Park, Cambridge, CB21 6GH, UK.
Ffytche D; Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, SE5 8AF, UK.
Gunn RN; Invicro & Department of Brain Sciences, Burlington Danes Building, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK.
Kocagoncu E; Medical Research Council Cognition and Brain Sciences Unit, Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 7EF, UK.
Lawson J; Department of Psychiatry, University of Oxford, Headington, Oxford OX3 7JX, UK.
Malhotra PA; Department of Brain Sciences, Imperial College London, Charing Cross Campus, London W6 8RP, UK.
Ridha BH; Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Rowe JB; Medical Research Council Cognition and Brain Sciences Unit, Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 7EF, UK.
Thomas AJ; Translational and Clinical Research Institute, Newcastle University, Newcastle, UK.
Zamboni G; Nuffield Department of Clinical Neurosciences, Headington, University of Oxford, Oxford OX3 9DS, UK.
Buckley NJ; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford OX1 3QU, UK.; Department of Psychiatry, University of Oxford, Headington, Oxford OX3 7JX, UK.
Cader ZM; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford OX1 3QU, UK.; Nuffield Department of Clinical Neurosciences, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford OX1 3QU, UK.
Lovestone S; Department of Psychiatry, University of Oxford, Headington, Oxford OX3 7JX, UK.; Janssen Medical UK, 50-100 Holmers Farm Way, High Wycombe HP12 4EG, UK.
Wade-Martins R; Department of Physiology Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford OX1 3QU, UK.
DB Label
Database : MEDLINE
원문보기
Open Access (PubMed Central)  Open Access (OUP)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
57
Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study. 미리보기

학술저널

issue
Alzheimer's research & therapy [Alzheimers Res Ther] 2022 Oct 12; Vol. 14 (1), pp. 154. Date of Electronic Publication: 2022 Oct 12.
Author
Low A; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Box 189, Level E4 Cambridge Biomedical Campus, Cambridge, Cambridgeshire, CB2 0SP, UK. al927@medschl.cam.ac.uk.
Prats-Sedano MA; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Box 189, Level E4 Cambridge Biomedical Campus, Cambridge, Cambridgeshire, CB2 0SP, UK.
McKiernan E; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Box 189, Level E4 Cambridge Biomedical Campus, Cambridge, Cambridgeshire, CB2 0SP, UK.
Carter SF; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Box 189, Level E4 Cambridge Biomedical Campus, Cambridge, Cambridgeshire, CB2 0SP, UK.
Stefaniak JD; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Box 189, Level E4 Cambridge Biomedical Campus, Cambridge, Cambridgeshire, CB2 0SP, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Nannoni S; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Su L; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Box 189, Level E4 Cambridge Biomedical Campus, Cambridge, Cambridgeshire, CB2 0SP, UK.; Department of Neuroscience, University of Sheffield, Sheffield, UK.
Dounavi ME; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Box 189, Level E4 Cambridge Biomedical Campus, Cambridge, Cambridgeshire, CB2 0SP, UK.
Muniz-Terrera G; Centre for Dementia Prevention, University of Edinburgh, Edinburgh, UK.
Ritchie K; Centre for Dementia Prevention, University of Edinburgh, Edinburgh, UK.; INSERM, Montpellier, France.
Lawlor B; Institute of Neuroscience, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Naci L; Institute of Neuroscience, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Malhotra P; Division of Brain Science, Imperial College Healthcare NHS Trust, London, UK.
Mackay C; Department of Psychiatry, Oxford University, Oxford, UK.
Koychev I; Department of Psychiatry, Oxford University, Oxford, UK.
Ritchie CW; Centre for Dementia Prevention, University of Edinburgh, Edinburgh, UK.
Markus HS; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
O'Brien JT; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Box 189, Level E4 Cambridge Biomedical Campus, Cambridge, Cambridgeshire, CB2 0SP, UK.; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
DB Label
Database : MEDLINE
원문보기
Full Text Full Text (원문보기) PLinkFull Text (원문보기) Open Access (PubMed Central)  Open Access (BioMed Central)  OA (Springer)  등재 - SCOPUS  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
58
Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study. 미리보기

학술저널

issue
Journal of neurology [J Neurol] 2022 Aug; Vol. 269 (8), pp. 4299-4309. Date of Electronic Publication: 2022 Mar 13.
Author
Dounavi ME; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Box 189, Level E4 Cambridge Biomedical Campus, Cambridge, CB2 0SP, UK.
Newton C; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Box 189, Level E4 Cambridge Biomedical Campus, Cambridge, CB2 0SP, UK.
Jenkins N; Centre for Dementia Prevention, University of Edinburgh, Edinburgh, UK.
Mak E; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Box 189, Level E4 Cambridge Biomedical Campus, Cambridge, CB2 0SP, UK.
Low A; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Box 189, Level E4 Cambridge Biomedical Campus, Cambridge, CB2 0SP, UK.
Muniz-Terrera G; Centre for Dementia Prevention, University of Edinburgh, Edinburgh, UK.
Williams GB; Department of Clinical Neurosciences and Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
Lawlor B; Institute of Neuroscience, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Naci L; Institute of Neuroscience, Trinity College Dublin, University of Dublin, Dublin, Ireland.
Malhotra P; Division of Brain Science, Imperial College Healthcare NHS Trust, London, UK.
Mackay CE; Department of Psychiatry, Oxford University, Oxford, UK.
Koychev I; Department of Psychiatry, Oxford University, Oxford, UK.
Ritchie K; Centre for Dementia Prevention, University of Edinburgh, Edinburgh, UK.; INM, Univ Montpellier, INSERM, Montpellier, France.
Ritchie CW; Centre for Dementia Prevention, University of Edinburgh, Edinburgh, UK.
Su L; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Box 189, Level E4 Cambridge Biomedical Campus, Cambridge, CB2 0SP, UK.; Department of Neuroscience, University of Sheffield, Sheffield, UK.
O'Brien JT; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Box 189, Level E4 Cambridge Biomedical Campus, Cambridge, CB2 0SP, UK. john.obrien@medschl.cam.ac.uk.
DB Label
Database : MEDLINE
원문보기
등재 - SCOPUS  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
60
Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. 미리보기

학술저널

issue
Brain communications [Brain Commun] 2021 Dec 17; Vol. 4 (1), pp. fcab297. Date of Electronic Publication: 2021 Dec 17 (Print Publication: 2022).
Author
Badenoch JB; Barts Health NHS Trust, London, UK.
Rengasamy ER; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Watson C; Barts Health NHS Trust, London, UK.
Jansen K; Department of Psychology, University of Münster, Münster, Germany.
Chakraborty S; Department of Physical Medicine and Rehabilitation, Christian Medical College and Hospital, Vellore, India.
Sundaram RD; School of Medicine, University of Glasgow, Glasgow, UK.
Hafeez D; Homerton University Hospitals Foundation Trust, London, UK.
Burchill E; Faculty of Medicine and Life Sciences, King's College London, London, UK.
Saini A; Medical School, University College London, London, UK.
Thomas L; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Cross B; East Lancashire Hospitals NHS Trust, Lancashire, UK.
Hunt CK; Warwick Medical School, Coventry, UK.
Conti I; School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
Ralovska S; Sofia University 'St Kliment Ohridski', bul, 'Tsar Osvoboditel' 15, Sofia, Bulgaria.
Hussain Z; Edinburgh Medical School, College of Medicine and Veterinary Medicine, University of Edinburgh, UK.
Butler M; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Pollak TA; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Koychev I; Department of Psychiatry, University of Oxford, Oxford, UK.
Michael BD; Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK.
Holling H; Department of Psychology, University of Münster, Münster, Germany.
Nicholson TR; Section of Cognitive Neuropsychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Rogers JP; Division of Psychiatry, University College London, London, UK.
Rooney AG; Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK.
DB Label
Database : MEDLINE
원문보기
Open Access (PubMed Central)  Open Access (OUP)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
  6 7 8 9 10  
바구니보기

QUICK LINK

  • 희망도서신청
  • 대출/연장조회
  • 서가부재도서
  • 이용교육

마이메뉴추가

QRCode
  • 개인정보호정책
  • 이메일무단수집거부
  • 도서관이용문의

    • 도서관자치위원회  원격제어  Instagram  facebook  w  kakao 플친
500-757 광주광역시 북구 용봉로 77 TEL 062)530-3571~2(대출반납실) FAX 062)530-3529
Copyright@2013 CHONNAM NATIONAL UNIVERSITY LIBRARY, All Rights Reserved.
  • 94630
  • 129868449